Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Abcam (ABCM) shares

Learn how to easily invest in Abcam shares.

Abcam is a biotechnology business based in the US. Abcam stocks (ABCM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $19 – a decrease of 5.83% over the previous week. Abcam employs 1,650 staff and has a trailing 12-month revenue of around $297.7 million.

How to buy shares in Abcam

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ABCM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Abcam stock price (NASDAQ:ABCM)

Use our graph to track the performance of ABCM stocks over time.

Abcam shares at a glance

Information last updated 2022-01-16.
Latest market close$16.80
52-week range$17.14 - $24.38
50-day moving average $22.29
200-day moving average $20.74
Wall St. target price$1,673.17
PE ratio 182.0408
Dividend yield $0 (0%)
Earnings per share (TTM) $0.10

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Abcam stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Abcam price performance over time

Historical closes compared with the close of $16.8 from 2022-01-21

1 week (2022-01-14) -5.83%
1 month (2021-12-22) -24.29%
3 months (2021-10-22) -26.15%
6 months (2021-07-22) -6.98%
1 year (2021-01-22) -28.78%
2 years (2020-01-18) N/A
3 years (2019-01-18) N/A
5 years (2017-01-18) N/A

Is Abcam under- or over-valued?

Valuing Abcam stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abcam's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Abcam's P/E ratio

Abcam's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 182x. In other words, Abcam shares trade at around 182x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Abcam's EBITDA

Abcam's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $61 million.

The EBITDA is a measure of a Abcam's overall financial performance and is widely used to measure a its profitability.

Abcam financials

Revenue TTM $297.7 million
Operating margin TTM 11.29%
Gross profit TTM $211.8 million
Return on assets TTM 2.57%
Return on equity TTM 2.85%
Profit margin 5.44%
Book value $2.81
Market capitalisation $4.2 billion

TTM: trailing 12 months

Abcam share dividends

We're not expecting Abcam to pay a dividend over the next 12 months.

Have Abcam's shares ever split?

Abcam's shares were split on a 5:1 basis on 1 December 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Abcam shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Abcam shares which in turn could have impacted Abcam's share price.

Abcam share price volatility

Over the last 12 months, Abcam's shares have ranged in value from as little as $17.14 up to $24.38. A popular way to gauge a stock's volatility is its "beta".

ABCM.US volatility(beta: 0.58)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcam's is 0.5771. This would suggest that Abcam's shares are less volatile than average (for this exchange).

Abcam overview

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. It also sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site